microenvironment. [1] [2] [3] [4] [5] [6] Although the underlying biological mechanisms of tumor-specific adiposederived stem cell migration are largely unknown, studies have suggested various contributory pathways such as stromal cell-derived factor-1/CXC receptor-4; platelet-derived growth factor BB/ platelet-derived growth factor receptor-β; C-C chemokine receptor-5/RANTES (regulated on activation, normal T cell expressed and secrete); insulin-like growth factor-1 receptor/insulin-like growth factor; and interleukin-8 receptor/interleukin-8. [7] [8] [9] [10] Further clarification of these pathways has led to increasing interest in the use of tumor-localizing adipose-derived stem cells for site-specific gene therapy and nanoparticle and drug delivery. [11] [12] [13] Growing evidence also suggests that adipose-derived stem cells facilitate tumor growth, angiogenesis, immune evasion, and metastasis. 2, 14, 15 Inflammatory chemokines found in the tumor microenvironment may be responsible for the integration of adipose-derived stem cells into the tumor stroma. 16 It is thought that the tumor microenvironment may simulate a site of chronic inflammation, resulting in the increased secretion of soluble factors that are responsible for promoting the integration of adipose-derived stem cells into the tumor stroma. 16, 17 This concept has been demonstrated using in vitro mammosphere models, and also partially elucidated by means of in vivo models. 17, 18 The unique ability of adiposederived stem cells to migrate and integrate into tumors makes them ideal vehicles for the targeted delivery of cancer therapeutics.
The development of a targeted delivery system that effectively uses adipose-derived stem cells requires both the ability to track adipose-derived stem cells from the point of entry through migration to the tumor and a therapeutic strategy that exploits the ability of adipose-derived stem cells to localize to the tumor cells. Our group has investigated the use of a novel nanoparticle for tracking adipose-derived stem cells while exploiting this optical label in a unique therapeutic approach.
With respect to cell tracking, one obstacle limiting the use of adipose-derived stem cells is the inability to monitor live cells in real time at multiple time points. 19, 20 The current gold standard cellular label, Qtracker (red-fluorescent Qdot 655 nanocrystals; Invitrogen, Waltham, Mass.), permits short-term cell tracking but does not provide high spatial resolution, limiting its use for whole-body imaging. 21 A nanoparticle with a more sensitive imaging capability would allow for in situ localization of cells within a given tumor. This would allow for the use of stem cells, or other cells, to be efficiently monitored when used as a cancer therapeutic in experimental or clinical trials.
Our laboratory has developed unique plasmonic-active nanoplatforms known as gold nanostars that are synthesized without cytotoxic chemicals (such as free cetyltrimethylammonium bromide), and accumulate intracellularly by means of micropinocytosis following conjugation with the transactivator of transcription peptide. [22] [23] [24] In addition, the unique two-photon luminescence of gold nanostars allows for direct particle visualization under multiphoton microscopy, and real-time imaging. 23 In addition to the two-photon photoluminescence properties, the gold nanostars are able to efficiently transform nonharmful light energy into heat to thermally ablate cells. 22, 25 The concept of photothermal ablation involves the application of a low-intensity laser (to the surface of the skin) to activate nanoparticles localized within deeper tissues. These nanoparticles subsequently convert the light energy into heat, triggering thermal ablation with ensuing cell death. 22, 26 Efficient photothermal ablation requires an even gold nanostar distribution within the target tissue. 27 The recently described tumor-targeting effect of stem cells suggests their use as site-specific drug carriers to deliver gold nanostars to the tumor site, resulting in an even intratumoral nanoparticle distribution. 28 The research reported here includes the following: (1) determination of whether gold nanostars alter the stem-like phenotype of adipose-derived stem cells; (2) investigation of the use of gold nanostars as long-term two-photon photoluminescence labels to monitor adipose-derived stem cells throughout trilineage differentiation; and (3) demonstration of the feasibility of using gold nanostar-labeled adipose-derived stem cells as targeted platforms for efficient photothermal ablation of stem cells and surrounding cancer cells in a co-culture model.
MATERIALS AND METHODS

Cell Lines and Culture Conditions
Human adipose-derived stem cells were purchased from Zen-Bio, Inc. (Research Triangle Park, N.C.) and maintained in preadipocyte medium (PM-1; Zen-Bio). The adipose-derived stem cells were confirmed by the supplier using flow cytometry before shipment to stain greater than 99 percent positive for CD105 and CD44 and negative for CD31 and CD45. SKBR3 cells (human adenocarcinoma of the breast, pleural Plastic and Reconstructive Surgery • April 2017 effusion) were obtained from ATCC (Manassas, Va.). Cell lines were maintained at 37°C in 5% carbon dioxide and supplemented with fresh media (PM-1) every 2 to 3 days. Adipose-derived stem cells from serial passages 2 through 5 were used for all experiments.
Gold Nanostar Preparation
All chemicals were purchased from SigmaAldrich (St. Louis, Mo.). Gold nanostars were prepared by a surfactant-free method as described previously. 22 Briefly, citrate-capped gold seeds were prepared by adding 15 ml of 1% trisodium citrate to 100 ml of boiling chloroauric acid solution (1 mM) under vigorous stirring for 15 minutes. The solution was cooled to room temperature and filtered by a 0.22-µm nitrocellulose membrane and stored at 4°C. Gold nanostars were prepared by simultaneously mixing 1 ml of 3 mM silver nitrate and 500 µl of 0.1 M ascorbic acid into 100 ml of 0.25 mM chloroauric acid containing hydrochloric acid (100 µl, 1 N) and citrate gold seeds (1 ml; optical density at 520 nm, 2.8). Polyethylene glycol-gold nanostars were prepared by adding 5 µM of SHPEG 5000 (O-[2-(3mercaptopropionylamino) ethyl]-O′-methylpolyethlene-glycol) to freshly synthesized gold nanostars for 15 minutes. Lastly, transactivator of transcription gold nanostars were prepared by mixing a final solution of 100 µM of cysteine-transactivator of transcription-peptide (residues 49 to 57, sequence Arg-Lys-Lys-Arg-ArgArg-Gln-Arg-Cys-CONH 2 ; SynBioSci, Livermore, Calif.) with 1 nM of polyethylene glycol-gold nanostar solution for 48 hours at 4°C followed by two centrifugal washes in ethanol.
Nanoparticle Uptake into Adipose-Derived Stem Cells
Solutions of gold nanostars and a commercially available nanoparticle cell label, Qtracker625 (Invitrogen) were prepared for cellular incubation by suspension in phosphate-buffered saline. Cells were incubated with the appropriate particle-containing solution (final concentration, 0.14 nM) for 24 hours before experimental use.
Co-Culture of Gold Nanostar-Labeled AdiposeDerived Stem Cells and SKBR3 Breast Cancer Cells
Gold nanostar-labeled adipose-derived stem cells and SKBR3 cells were seeded at a ratio of 1:1 (20,000 cells/cm 2 ), incubated overnight, and supplemented with fresh PM-1 media before laser treatment.
Flow Cytometry
The surface antigens of unlabeled adiposederived stem cells, as compared to gold nanostar-labeled adipose-derived stem cells, were characterized by flow cytometry; 1 × 10 6 cells/ tube were stained with monoclonal antibodies against CD90 (allophycocyanin), CD105 (phycoerythrin), CD45 (PE-Cy5) and immunoglobulin G1 control, CD31 (AF-700) and immunoglobulin G1 control, and CD44 (BV-421). All antibodies were purchased from BioLegend (San Diego, Calif.). Analysis was performed on a BD LSRII cytometer (Becton Dickinson, San Jose, Calif.). For each sample, 100,000 events were collected; the data were analyzed with FlowJo (FlowJo, LLC, Ashland, Ore.).
Two-Photon Photoluminescence Comparison between Gold Nanostar-Labeled AdiposeDerived Stem Cells and Qtracker-Labeled Adipose-Derived Stem Cells
After labeling of adipose-derived stem cells with gold nanostar and Qtracker, cells were plated and supplemented daily with fresh growth media. On the first, second, and fourth days, the plates were fixed with 4% paraformaldehyde before imaging by multiphoton microscopy. To assess intracellular particle distribution, the cells were stained with Hoechst33342 (Invitrogen). The degree of calculated total cell two-photon photoluminescence was derived using ImageJ (National Institutes of Health, Bethesda, Md.) as performed previously.
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Multilineage Differentiation of Gold NanostarLabeled Adipose-Derived Stem Cells
Gold nanostar-labeled adipose-derived stem cells were analyzed for their capacity to differentiate along adipogenic, osteogenic, and chondrogenic lineages and monitored using multiphoton microscopy. In all samples, the two-photon photoluminescence signal of gold nanostars was compared to Qtracker over 21 days. For both adipogenesis and osteogenesis, the cells were maintained in PM-1 media until approximately 100 percent confluence was achieved. The cells were then differentiated using adipocyte (DM-2; ZenBio) and osteoblast (OB-1; Zen-Bio) differentiation media. Complete adipogenic and osteogenic differentiation was evaluated using Oil Red O and Alizarin red S staining, respectively. For chondrogenesis, a micromass culture protocol was used. A 25-µl droplet (80,000 cells) was placed in the center of each well, incubated for 2 hours at 37°C, and then supplemented with 2 ml of chondrocyte differentiation media (CM-1; Zen-Bio) for 21 days. Alcian blue stain was used to confirm differentiation. On days 7 and 21 of differentiation, images were taken with multiphoton microscopy to monitor the two-photon photoluminescence emitted from gold nanostar and Qtracker.
Multiphoton Microscopy Imaging
All multiphoton microscopic images were taken using a multiphoton microscope (Olympus FV1000; Olympus America, Center Valley, Pa.) at the Light Microscopy Core Facility, Duke University. Imaging was carried out with a femtosecond titanium:sapphire laser (Chameleon Vision II; Coherent, Santa Clara, Calif.) with a 680-to 1080-nm tunable range, a 140-fsec pulse width, and an 80-MHz repetition rate. Images were taken under 800-nm excitation and 3.7 mW unless otherwise noted. All images were collected and reconstructed using ImageJ.
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Trypan Blue Cell Viability and 3-(4,5-Dimethylthiazolyl-2)-2,5-Diphenyltetrazolium Bromide Proliferation Assays
A trypan blue viability assay was used to distinguish the number of live and dead cells in undifferentiated adipose-derived stem cells labeled with gold nanostars and Qtracker. Concentrations of 0.05, 0.1, and 0.14 nM of gold nanostars and Qtracker were incubated with adipose-derived stem cells for 24 hours; dead cells were enumerated using the Cellometer Auto 2000 (Nexcelom Bioscience, Lawrence, Mass.).
A 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) (Sigma) assay was used to compare cellular proliferation in undifferentiated adipose-derived stem cells labeled with gold nanostars and Qtracker. In this assay, MTT is reduced by metabolically active cells and quantified by spectrophotometry. Gold nanostar and Qtracker concentrations of 0.05, 0.1, and 0.14 nM were used. The absorbance was determined using a spectrophotometer (FLUOstar Optima; BMG Biotech, Ortenberg, Germany).
In Vitro Photothermal Therapy
Adipose-derived stem cells were incubated with gold nanostars and then seeded onto 35-mm Petri dishes. For photothermal therapy, cells on a 37°C heating stage of a multiphoton microscope were exposed to the 800-nm wavelength of a titanium:sapphire laser at output powers of 2.19, 3.7, or 9.14 mW for 3 minutes. Adipose-derived stem cells cultured with untreated media were used as controls and received the same laser treatment. Immediately after treatment, cells were examined under a fluorescence microscope using fluorescein diacetate and propidium iodide.
Photothermal therapy was applied to gold nanostar-labeled adipose-derived stem cells and cancer cell co-cultures. For photothermal therapy, cells were kept on a 37°C heating stage and exposed to an 800-nm laser at 3.7 mW for 3 minutes. Cancer cells cultured with unlabeled adipose-derived stem cells were used as controls and received the same laser treatment. Immediately after treatment, cells were examined using fluorescein diacetate and propidium iodide.
Statistical Analysis
Data are expressed as means ± SEM. Statistical comparisons of the calculated degree of two-photon luminescence were analyzed with GraphPad Prism 6 (GraphPad Software, Inc., La Jolla, Calif.) using a two-way analysis of variance. Furthermore, a t test was used for analysis of proliferation and viability data. A value of p < 0.05 was considered statistically significant.
RESULTS
Signal Intensity Is Higher for Gold NanostarLabeled Adipose-Derived Stem Cells Than for Qtracker-Labeled Adipose-Derived Stem Cells throughout Proliferation
In vitro experiments were performed to assess the localization of gold nanostars into adiposederived stem cells and to directly compare gold nanostars to Qtracker as an optical label. Figure 1 demonstrates the predominant two-photon photoluminescence signal of gold nanostars in the adipose-derived stem cell cytoplasm, visualized using multiphoton microscopy. Figure 2 displays the two-photon photoluminescence signal profiles of both gold nanostars (white) and Qtracker (red) in adipose-derived stem cells over 4 days. Although two-photon photoluminescence signals of both Qtracker and gold nanostars decreased over time, the signal intensity was higher for the gold nanostar-labeled adipose-derived stem cells. In addition, the rate of signal decay was decreased for cells labeled with gold nanostars. Statistical analysis using a two-way analysis of variance showed a significantly higher degree (p < 0.0001) of integrated total cell two-photon photoluminescence signal throughout the 4-day period in gold nanostar-labeled adipose-derived stem cells. 
Gold Nanostars Are Visualized throughout Trilineage Differentiation of Adipose-Derived Stem Cells
To evaluate whether gold nanostar-labeled adipose-derived stem cells maintain the capacity for trilineage differentiation, gold nanostarlabeled adipose-derived stem cells were cultured in lineage-specific differentiation media for 21 days. Qtracker-labeled adipose-derived stem cells were also differentiated to compare the two-photon photoluminescence properties of both optical labels (Fig. 3) . After 21 days, cells were stained to validate their differentiated phenotype. In addition, images were captured using multiphoton microscopy throughout differentiation. Imaging began at 7 days for adipogenesis (Fig. 3) , osteogenesis, and chondrogenesis. Gold nanostar-labeled adiposederived stem cells exhibited strong two-photon photoluminescence throughout differentiation, with only slight decay in signal over time. Therefore, the decrease in signal intensity in these gold nanostar-labeled adipose-derived stem cells did not preclude the use of multiphoton microscopy. In comparison, Qtracker-labeled cells exhibited such rapid signal decay that, by day 21, cells were not easily visualized (Fig. 3) . Analysis of gold nanostarand Qtracker-labeled cells using a two-way analysis of variance demonstrated significantly greater two-photon photoluminescence (p < 0.001) for gold nanostars throughout trilineage differentiation. Lastly, the cytoplasmic localization of the gold nanostars remained undisrupted in all three lineages as demonstrated with Hoechst33342 staining.
Gold Nanostar-Labeled Adipose-Derived Stem Cells Are Photoactivated, Killing Adipose-Derived Stem Cells and Surrounding Cancer Cells
Live/dead fluorescent staining was used to determine whether the photothermal response generated by gold nanostar-labeled adiposederived stem cells was robust enough to induce thermolysis after laser photoactivation at varying intensities. The unlabeled adipose-derived stem cells were fully viable after all treatments, whereas the gold nanostar-labeled adipose-derived stem cells demonstrated significant cell death (Fig. 4) . The most efficient treatment method was found to be 3 minutes with a laser power of 3.7 mW. In co-culture experiments of gold nanostar-labeled adipose-derived stem cells with SKBR3 cells, a distinct area of ablation was seen. Dead cells (stained red) had a tendency to remain in the center of the zone of ablation or detach from the treated area (Fig. 5) . Co-cultures of unlabeled adipose-derived stem cells and SKBR3 cells demonstrated no cell death following photothermal treatment.
Fig. 2.
Comparison of two-photon photoluminescence in gold nanostar-versus Qtracker-labeled adiposederived stem cells. Undifferentiated adipose-derived stem cells are shown after a 24-hour incubation with 0.14-nM gold nanostars (above) and 0.14-nM Qtracker (below) (scale bars = 50 µm). Cells were fixed on days 1, 2, and 4 and then imaged to determine the relative fluorescence of each optical label. Each cell could be roughly distinguished by its predominant fluorescence. Qtracker (red) and gold nanostars (white) could be seen in each cell. Fluorescence was measured over a period of 4 days. Calculated total cell fluorescence was calculated with ImageJ and analyzed using a two-way analysis of variance. There was a significantly greater degree of fluorescence emitted by those cells labeled with gold nanostars versus Qtracker throughout all 4 days of cellular proliferation (p < 0.0001). Multiphoton microscopic images were taken at 800 nm using a laser power of 3.7 mW.
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DISCUSSION
This study demonstrates that gold nanostars can effectively label adipose-derived stem cells in both undifferentiated and differentiated states without significantly altering cell phenotype and viability. The data also confirm that the high photothermal conversion efficiency of gold nanostars generates enough thermal energy to kill nanoparticle-containing stem cells and surrounding breast cancer cells.
The small size and sensitive imaging properties of gold nanoparticles have made them increasingly attractive for cellular imaging and cancer therapy. 31, 32 Because tumor cells are highly susceptible to heat, hyperthermic therapy as an adjunctive treatment for cancer has been previously investigated. 33, 34 Under laser exposure, the gold nanostar absorbs light energy and converts it to heat, which disrupts the cell membrane and causes cell ablation. 35 However, success with nanoparticle-based therapeutics has been limited because of heterogeneous tumoral distribution of the nanoparticles. Stem cell-mediated gold nanostar delivery may provide a solution to this problem. It is well established that stem cells of mesenchymal origin demonstrate tropism to tumors. [36] [37] [38] This property has generated increased interest in the use of stem cells as vehicles for targeted drug delivery; however, one obstacle to the development of stem cell therapies is the inability to track administered cells in vivo over a prolonged period. The authors of this study aimed to investigate the use of gold nanostars as a vividly fluorescent stem cell label and as a potential cancer therapeutic when delivered with adipose-derived stem cells.
Snapshot images of cell location are insufficient to fully elucidate the migration, differentiation, and proliferative fate of transplanted cells. 39, 40 To confirm the proper migration of stem cells to their target in clinical practice, reliable imaging For adipogenesis, the cells labeled with gold nanostars could be easily visualized over a period of 21 days and to a greater extent than with the Qtracker label. Results similar to those shown in this figure were seen in osteogenesis and chondrogenesis as well. All samples were imaged with multiphoton microscopy using a wavelength of 800 nm at 3.7 mW.
techniques are required. 41, 42 This study indicates that gold nanostars provide a strong two-photon photoluminescence signal over a clinically relevant time course, which can be used to track labeled stem cells used in a therapeutic application. Prior studies have shown that gold nanostars can also be visualized in vivo using multiple modalities of whole-body imaging including positron emission tomography, computed tomography, and magnetic resonance imaging. 43 The unique ability of this gold nanoparticle to be imaged for an extended period across multiple imaging platforms will provide the most comprehensive information for stem cell therapy in the clinical setting. 20, [44] [45] [46] The application of two-photon photoluminescence microscopy as a noninvasive imaging technique of living tissues has garnered significant interest because of the high signal-to-noise ratio in nanoparticle imaging. Qtracker is one of the most promising commercially available twophoton photoluminescence labels available for cellular tracking. However, there are several drawbacks to Qtracker that limit its in vivo use, including multiexponential signal decay and relative cytotoxicity. 47, 48 Our studies demonstrate that gold nanostars exhibit a superior intracellular retention and stronger two-photon photoluminescence signal in both differentiated and undifferentiated cells. Throughout proliferation and differentiation, the fluorescent properties of gold nanostarlabeled adipose-derived stem cells were easily detected, whereas cells labeled with Qtracker displayed significant signal decay. The large size of the gold nanostars and resulting cellular retention may account for the higher longevity and degree of two-photon photoluminescence signal intensity compared with Qtracker. 49, 50 The gold nanostars used in these studies are advantageous because, in addition to their luminescent signal, these nanoparticles have a high photon-to-heat conversion efficiency that allows for their potential application in cancer therapy. 44, 47 This allows for superior nanotherapeutic capabilities in comparison with other commonly used nanoparticles. 23, [51] [52] [53] [54] To successfully implement the use of stem cells as nanoparticle carriers, it is important to load cells with gold nanostars without significantly altering their intrinsic properties or reducing viability. 28 Our data demonstrate that gold nanostars do not alter the phenotype of adipose-derived stem cells and do not impede differentiation. Our studies suggest a slight decrease in cell viability following a 24-hour incubation with either gold Fig. 4 . Photothermal therapy effects on gold nanostar-labeled adipose-derived stem cells (GNS-ASC) in monoculture. Adiposederived stem cells were incubated with unlabeled medium (control) and gold nanostars for 24 hours at 37°C and then exposed to an 800-nm laser for 3 minutes using multiphoton microscopy. The laser powers used were 2.19, 3.7, and 9.14 mW. Cells were stained with fluorescein diacetate and propidium iodide, which stain live cells green and dead cells red, respectively; representative images are shown following laser exposure (scale bars = 100 µm). The control group displayed no cell death at any of the treatment powers. The empty area in the center of the images of gold nanostar-labeled adipose-derived stem cells demonstrates a clear zone of cellular ablation. A treatment power of 3.7 mW was found to be the most efficient and specific with respect to the size and area of ablation. This power was selected for use in the co-culture photothermal treatments.
Plastic and Reconstructive Surgery • April 2017 nanostars or Qtracker, indicating that significant cell death may occur at higher concentrations.
The concept of using cells as a delivery mechanism has proven to be an effective method to achieve an even distribution of nanoparticles at the tumor site, which is essential for therapeutic photothermal ablation. 27, [55] [56] [57] [58] However, there has been no previous investigation of adipose-derived stem cell-assisted targeted delivery of gold nanostars for photothermal ablation. Previous studies have focused on the use of bone marrowderived mesenchymal stem cells and neural stem cells, neither of which is as readily accessible for clinical use as adipose-derived stem cells, which can be easily harvested from the subcutaneous fat of patients. [59] [60] [61] In addition, other studies have focused on the use of nanorods and nanoshells, both of which are less effective in photothermal treatment than gold nanostars. 62 As demonstrated in our studies, the nanoparticles in the adiposederived stem cells produce enough heat to ablate not only the stem cells, but also surrounding cancer cells. The long-term goal of this project is to provide therapeutic delivery of gold nanostar-labeled adipose-derived stem cells, which then migrate to the tumor bed and can be noninvasively photoactivated to ablate cancer cells by laser pulsation through the overlying skin. The work presented in this study establishes the basis for future in vivo models investigating stem cell delivery of gold nanostars to tumor sites, with subsequent photothermal ablation of cancer.
CONCLUSIONS
Gold nanostar-labeled adipose-derived stem cells exploit the tumor tropism of adipose-derived stem cells, which may allow for site-specific photothermal ablation in cancer therapy. This study demonstrates efficient uptake of gold nanostars by adipose-derived stem cells and two-photon photoluminescence signal persistence over 21 days in culture, and minimal effects of the nanoparticle on cell viability, proliferation, and multilineage differentiation. Photothermal ablation was effective in destroying labeled adipose-derived stem cells and neighboring cancer cells, although it did not appear to harm unlabeled cells. Future studies will use an in vivo breast cancer mouse model to optimize tracking and photothermal ablation of the gold nanostar-labeled adipose-derived stem cells following implantation. 
